Jw. Ensinck et al., ENDOGENOUS SOMATOSTATIN-28 MODULATES POSTPRANDIAL INSULIN-SECRETION IMMUNONEUTRALIZATION STUDIES IN BABOONS, The Journal of clinical investigation, 100(9), 1997, pp. 2295-2302
Somatostatin-28 (S-28), secreted into the circulation from enterocytes
after food, and S-14, released mainly from gastric and pancreatic D c
ells and enteric neurons, inhibit peripheral cellular functions. We hy
pothesized that S-28 is a humoral regulator of pancreatic B cell funct
ion during nutrient absorption. Consistent with this postulate, we obs
erved in baboons a two to threefold increase in portal and peripheral
levels of S-28 after meals, with minimal changes in S-14. We attempted
to demonstrate a hormonal effect of these peptides by measuring their
concentrations before and after infusing a somatostatin-specific mono
clonal antibody (mAb) into baboons and comparing glucose, insulin, and
glucagon-like peptide-1 levels before and for 4 h after intragastric
nutrients during a control study and on 2 d after mAb administration (
days 1 and 2). Basal growth hormone (GH) and glucagon levels and param
eters of insulin and glucose kinetics were also measured. During immun
oneutralization, we found that (a) postprandial insulin levels were el
evated on days 1 and 2; (b) GH levels rose immediately and were sustai
ned for 28 h, while glucagon fell; (c) basal insulin levels were uncha
nged on day 1 but were increased two to threefold on day 2, coincident
with decreased insulin sensitivity; and (d) plasma glucose concentrat
ions were similar to control values. We attribute the eventual rise in
fasting levels of insulin to its enhanced secretion in compensation f
or the heightened insulin resistance from increased GH action. Based o
n the elevated postmeal insulin levels after mAb administration, we co
nclude that S-28 participates in the enteroinsular axis as a decretin
to regulate postprandial insulin secretion.